Clinical manifestations are mainly represented by mucous membrane and soft tissue bleeding and their severity is variable depending on the degree of VWF and FVIII reduction.2 Women with VWD are at particularly high risk of bleeding because of menorrhagia and delivery. This evidence concerns the gene VWF and von Willebrand disease (hereditary or acquired).